Page last updated: 2024-08-17

medroxyprogesterone acetate and Coronary Artery Disease

medroxyprogesterone acetate has been researched along with Coronary Artery Disease in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (26.32)	18.2507
2000's	14 (73.68)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Thacker, HL	1
Bølling, S; Djurovic, S; Os, A; Os, I; Sandset, PM; Seljeflot, I; Westheim, A	1
Alderman, EL; Bittner, V; Cobb, FR; Gordon, DJ; Higginson, L; Howard, BV; Hsia, J; Ouyang, P; Proschan, M; Rogers, WJ; Steffes, M; Tardif, JC; Thompson, P; Verter, JI; Waters, DD; Younes, N	1
Azen, SP; Cashin-Hemphill, L; Faxon, DP; French, WJ; Gaarder, TD; Hodis, HN; Lobo, RA; Mack, WJ; Mahrer, PR; Mehra, AO; Rabbani, R; Sanmarco, ME; Selzer, RH; Sevanian, A; Shil, AB; Shook, TL; Shoupe, D; Torres, M; Vogelbach, KH	1
Abdelnoor, M; Birkeland, K; Larsen, A; Os, A; Os, I; Westheim, A	1
Alderman, EL; Howard, BV; Hsia, J; Lindsay, J; Ouyang, P; Silverman, A; Tripputi, M; Van Voorhees, L; Waters, DD	1
Herrington, DM; Kowalchuk, GJ; Nair, GV; Rogers, W; Stuckey, TD; Waters, D	1
Cobb, F; Howard, BV; Kelemen, M; Ouyang, P; Tripputti, M; Vaidya, D; Waters, DD; Younes, N	1
Eriksson-Berg, M; Håkan Wallén, N; Hjemdahl, P; Landgren, BM; Li, N; Schenck-Gustafsson, K	1
Becker, A; Becker, C; Knez, A; Leber, A; von Ziegler, F	1
Herrington, DM; Kowalchuk, G; Reboussin, DM; Waters, D; Yeboah, J	1
Clarkson, TB; Honoré, EK; Washburn, SA; Williams, JK	1
Adams, MR; Golden, DL; Register, TC; Wagner, JD; Williams, JK	1
Delansorne, R; Paris, J; Williams, JK	1
Barnabei, VM; Hsia, J; Phillips, TM	1
Abdelnoor, M; Birkeland, K; Brekke, M; Hofstad, AE; Jacobsen, AF; Larsen, A; Midtbo, K; Nesheim, BI; Os, I; Westheim, A	1
Cheshire, K; Folmar, S; Herrington, D; Macer, J; Oates-Williams, F; Potvin Klein, K; Reboussin, D; Sharp, P; Smith, J	1
Clarkson, TB	1
Boothroyd, D; Hlatky, MA; Sharp, P; Vittinghoff, E; Whooley, MA	1

Reviews

1 review(s) available for medroxyprogesterone acetate and Coronary Artery Disease

Article	Year
Progestogens and cardiovascular disease. A critical review. The Journal of reproductive medicine, 1999, Volume: 44, Issue:2 Suppl Topics: Cardiovascular Diseases; Coronary Artery Disease; Disease Progression; Estrogens; Female; Hormone Replacement Therapy; Humans; Hyperglycemia; Insulin Resistance; Lipoproteins, LDL; Medroxyprogesterone Acetate; Progesterone Congeners; Progestins	1999

Trials

13 trial(s) available for medroxyprogesterone acetate and Coronary Artery Disease

Article	Year
Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine. Cardiology, 2002, Volume: 98, Issue:1-2 Topics: Administration, Cutaneous; Age Factors; Aged; Biomarkers; Body Mass Index; C-Peptide; Coronary Artery Disease; E-Selectin; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Severity of Illness Index; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Women's Health	2002
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA, 2002, Nov-20, Volume: 288, Issue:19 Topics: Aged; Antioxidants; Ascorbic Acid; Coronary Angiography; Coronary Artery Disease; Dietary Supplements; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk; Statistics, Nonparametric; Vitamin E	2002
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. The New England journal of medicine, 2003, Aug-07, Volume: 349, Issue:6 Topics: Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Patient Compliance; Postmenopause; Treatment Failure	2003
Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:3 Topics: Administration, Cutaneous; Aged; Blood Glucose; Body Mass Index; C-Peptide; Climacteric; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Estradiol; Female; Humans; Insulin; Leptin; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Treatment Outcome	2003
Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance. Circulation, 2004, Jul-13, Volume: 110, Issue:2 Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Canada; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug Combinations; Estrogens, Conjugated (USP); Female; Fibrinogen; Follow-Up Studies; Glucose Intolerance; Hormone Replacement Therapy; Humans; Hysterectomy; Inflammation; Insulin; Insulin Resistance; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Prospective Studies; Single-Blind Method; Triglycerides; United States	2004
Pulse pressure and coronary atherosclerosis progression in postmenopausal women. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:1 Topics: Aged; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Disease Progression; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Single-Blind Method; Vascular Resistance	2005
Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis, 2005, Volume: 179, Issue:1 Topics: Aged; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Postmenopause; Treatment Failure; Vasodilation; Vitamin E	2005
No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease. Thrombosis and haemostasis, 2006, Volume: 96, Issue:6 Topics: Adenosine Diphosphate; Aged; beta-Thromboglobulin; Blood Platelets; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Leukocytes; Medroxyprogesterone Acetate; Middle Aged; P-Selectin; Platelet Adhesiveness; Platelet Function Tests; Postmenopause; Thrombin	2006
Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. American heart journal, 2007, Volume: 153, Issue:3 Topics: Aged; Brachial Artery; Contraceptive Agents, Female; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Female; Humans; Image Processing, Computer-Assisted; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Regional Blood Flow; Ultrasonography; Vasodilation	2007
Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Journal of women's health & gender-based medicine, 1999, Volume: 8, Issue:9 Topics: Arteriosclerosis; Coronary Artery Disease; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors	1999
The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoprotei Journal of internal medicine, 2000, Volume: 247, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Aged; Coronary Angiography; Coronary Artery Disease; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Risk Factors	2000
Recruitment of participants for the Estrogen Replacement and Atherosclerosis (ERA) trial. a comparison of costs, yields, and participant characteristics from community- and hospital-based recruitment strategies. Controlled clinical trials, 2001, Volume: 22, Issue:1 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Costs and Cost Analysis; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mass Screening; Medroxyprogesterone Acetate; Middle Aged; Patient Selection; Social Environment	2001
Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA, 2002, Feb-06, Volume: 287, Issue:5 Topics: Aged; Coronary Artery Disease; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fatigue; Female; Hot Flashes; Humans; Linear Models; Medroxyprogesterone Acetate; Mental Health; Multivariate Analysis; Physical Exertion; Postmenopause; Progesterone Congeners; Quality-Adjusted Life Years	2002

Other Studies

5 other study(ies) available for medroxyprogesterone acetate and Coronary Artery Disease

Article	Year
The case for hormone replacement: new studies that should inform the debate. Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:9 Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Coronary Artery Disease; Depression; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Assessment; Risk Factors	2002
Comparison of progression of coronary calcium in postmenopausal women on versus not on estrogen/progestin therapy. The American journal of cardiology, 2007, Feb-01, Volume: 99, Issue:3 Topics: Calcinosis; Calcium; Contraceptive Agents, Female; Coronary Artery Disease; Coronary Vessels; Disease Progression; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prognosis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed	2007
Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. Journal of the American College of Cardiology, 1994, Volume: 24, Issue:7 Topics: Animals; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Estrogen Replacement Therapy; Estrogens; Female; Macaca fascicularis; Medroxyprogesterone Acetate; Vasodilation	1994
Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:1 Topics: Administration, Oral; Animals; Coronary Artery Disease; Drug Antagonism; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Macaca fascicularis; Medroxyprogesterone Acetate; Ovariectomy; Progesterone Congeners	1997
Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys. The Journal of steroid biochemistry and molecular biology, 1998, Volume: 65, Issue:1-6 Topics: Acetylcholine; Animals; Coronary Artery Disease; Estrogens; Female; Macaca fascicularis; Male; Medroxyprogesterone Acetate; Megestrol; Norpregnadienes; Premenopause; Progestins; Sex Characteristics; Vasodilation; Vasodilator Agents	1998